In a computer-assessed, double-blinded, placebo-controlled clinical study, Prevagen improved certain aspects of cognitive function over a 90 day period in subgroups of individuals who were cognitively normal or mildly impaired.*
Prevagen is formulated with apoaequorin, which was originally discovered in jellyfish. Apoaequorin is safe and uniquely supports brain function.*